Biocon profit decreased 39.41% in (Q4) FY 2019-20

Source

Team Infinities:

Biocon Limited NSE Symbol:BIOCON, BSE Security Code:532523 has declared its 4th(fourth) quarter audited Consolidated financial report from the month of January, 2020 to the month of March, 2020; for the fiscal year 2019-20.

Revenue Reported by Biocon Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
16.44 17.84 15.57 65.29 56.59
Calculated Revenue of Biocon Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
1.40 7.85%(Revenue Decrease) 0.87 5.59%(Revenue Increase) 8.70 15.37%(Revenue Increase)

Revenue: Biocon Limited's financial report shows that the company's revenue decreased by 7.85% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for revenue decrease of Rs.1.40 billions, as the company posted revenue of Rs.16.44 billions; in compare to previous quarter(October, 2019 - December, 2019) when the company reported revenue of Rs.17.84 billions.
The result also shows that the company's revenue increased by 5.59% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for revenue increase of Rs.0.87 billion; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted revenue of Rs.15.57 billions.
The company also reported that its revenue increased by 15.37% in 12 months end(April, 2019 - March, 2020) for revenue increase of Rs.8.70 billions, since the company reported revenue of Rs.65.29 billions; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted revenue of Rs.56.59 billions.

Gross Margin(%) Reported by Biocon Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
64.95 65.41 57.74 61.46 58.00
Calculated Gross Margin(%) of Biocon Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
0.46 0.70%(GM Decrease) 7.21 12.50%(GM Increase) 3.46 5.97%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 0.70% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for 0.46% GM decrease, as the company reported 64.95% GM; in compare to previous quarter(October, 2019 - December, 2019) when the company reported 65.41% GM.
The result also indicates, the company's GM increased by 12.50% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for 7.21% GM increase; in compare to corresponding quarter(January, 2019 - March, 2019) when the company reported 57.74% GM.
The company also reported that its GM increased by 5.97% in 12 months end(April, 2019 - March, 2020) for 3.46% GM increase, since the company reported 61.46% GM; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company reported 58.00% GM.

EBITDA Reported by Biocon Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
3.37 4.50 3.91 16.80 16.36
Calculated EBITDA of Biocon Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
1.13 25.11%(EBITDA Decrease) 0.54 13.81%(EBITDA Decrease) 0.44 2.69%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA decreased by 25.11% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for EBITDA decrease of Rs.1.13 billions, as the company posted EBITDA of Rs.3.37 billions; in compare to previous quarter(October, 2019 - December, 2019) when the company reported EBITDA of Rs.4.50 billions.
The result also shows that the company's EBITDA decreased by 13.81% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for EBITDA decrease of Rs.0.54 billion; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted EBITDA of Rs.3.91 billions.
The company also reported that its EBITDA increased by 2.69% in 12 months end(April, 2019 - March, 2020) for EBITDA increase of Rs.0.44 billion, since the company reported EBITDA of Rs.16.80 billions; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted EBITDA of Rs.16.36 billions.

Profit and Loss Reported by Biocon Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
1.23(Profit ) 2.03(Profit ) 2.14(Profit ) 7.48(Profit ) 9.05(Profit )
Calculated Profit and Loss of Biocon Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
0.80 39.41%(Profit Decrease) 0.91 42.52%(Profit Decrease) 1.57 17.35%(Profit Decrease)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit decreased by 39.41% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for profit decrease of Rs.0.80 billion, as the company posted profit of Rs.1.23 billions; in compare to previous quarter(October, 2019 - December, 2019) when the company reported profit of Rs.2.03 billions.
The result also shows that the company's profit decreased by 42.52% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for profit decrease of Rs.0.91 billion; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted profit of Rs.2.14 billions.
The company also reported that its profit decreased by 17.35% in 12 months end(April, 2019 - March, 2020) for profit decrease of Rs.1.57 billions, since the company reported profit of Rs.7.48 billions; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted profit of Rs.9.05 billions.

EPS Reported by Biocon Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
1.04 1.71 1.81 6.32 7.65
Calculated EPS of Biocon Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
0.67 39.18%(EPS Decrease) 0.77 42.54%(EPS Decrease) 1.33 17.39%(EPS Decrease)

EPS /Earning per Share: The company's financial report shows that the company's EPS decreased by 39.18% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for EPS decrease of Rs.0.67, as the company posted EPS of Rs.1.04; in compare to previous quarter(October, 2019 - December, 2019) when the company reported EPS of Rs.1.71.
The result also shows that the company's EPS decreased by 42.54% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for EPS decrease of Rs.0.77; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted EPS of Rs.1.81.
The company also reported that its EPS decreased by 17.39% in 12 months end(April, 2019 - March, 2020) for EPS decrease of Rs.1.33, since the company reported EPS of Rs.6.32; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted EPS of Rs.7.65.

Assets Reported by Biocon Limited for Fourth Quarter FY, 2019-20
Details Non-current Assets Current Assets
Current Quarter(March, 2020) Previous Year End(March, 2019) Current Quarter(March, 2020) Previous Year End(March, 2019)
Reported 91.19 73.04 53.25 48.89
  Change Change % Change Change %
Calculated 18.15 24.85%(Assets Increase) 4.36 8.92%(Assets Increase)

Assets:The company reported its non-current assets increased by 24.85% in current year end(March, 2020) for non-current assets increase of Rs.18.15 billions, since the company reported net non-current assets of Rs.91.19 billions; in compare to previous year end(March, 2019) when the company reported net non-current assets of Rs.73.04 billions.
The balance sheet of the company also shows that, its current assets increased by 8.92% in current year end(March, 2020) for current assets increase of Rs.4.36 billions, as the company reported net current assets of Rs.53.25 billions; against previous year end(March, 2019) when the company reported net current assets of Rs.48.89 billions.

Liabilities Reported by Biocon Limited for Fourth Quarter FY, 2019-20
Details Non-current Liabilities Current Liabilities
Current Quarter(March, 2020) Previous Year End(March, 2019) Current Quarter(March, 2020) Previous Year End(March, 2019)
Reported 30.53 24.47 40.08 30.39
  Change Change % Change Change %
Calculated 6.06 24.77%(Liabilities Increase) 9.69 31.89%(Liabilities Increase)

Liabilities:The company reported its non-current liabilities increased by 24.77% in current year end(March, 2020) for non-current liabilities increase of Rs.6.06 billions, since the company reported net non-current liabilities of Rs.30.53 billions; in compare to previous year end(March, 2019) when the company reported net non-current liabilities of Rs.24.47 billions.
The balance sheet of the company also shows that, its current liabilities increased by 31.89% in current year end(March, 2020) for current liabilities increase of Rs.9.69 billions, as the company reported net current liabilities of Rs.40.08 billions; against previous year end(March, 2019) when the company reported net current liabilities of Rs.30.39 billions.


***All amounts are given in Billion Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.